Clinical Trial Update: Pembrolizumab Before Surgery for the Treatment of Mismatch Repair Deficient Locally Advanced Solid Cancers [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial evaluating pembrolizumab before surgery in mismatch repair–deficient locally advanced solid cancers has completed enrollment and pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Solid Tumor

Drugs mentioned

• Pembrolizumab (Keytruda) (pembrolizumab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Locally Advanced Malignant Solid Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2025-05-13